Average Co-Inventor Count = 7.86
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (10 from 1,536 patents)
2. Boehringer Ingelheim Pharmaceuticals, Inc. (2 from 276 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
12 patents:
1. 12139484 - Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease
2. 11130754 - Substituted benzamides as RIPK2 inhibitors
3. 10138222 - Substituted benzamides as RIPK2 inhibitors
4. 10138241 - Substituted benzamides as RIPK2 inhibitors
5. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
6. 8546442 - Pyrazolopiperidine compounds as CCR1 receptor antagonists
7. 8338610 - Pyridinyl compounds useful as intermediates
8. 8293917 - Pyrazole compounds as CCR1 antagonists
9. 8268859 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
10. 8063065 - Azaindazole compounds as CCR1 receptor antagonists
11. 7879873 - Azaindazole compounds as CCR1 receptor antagonists
12. 7115644 - Heterocyclic compounds